Lost in translation: revisiting the use of tyrosine kinase inhibitors in colorectal cancer

HIGHLIGHTS

• who: Kirti K. Iyer from the Laboratory-Clinic Interface Department of Medical Oncology, Radboud Institute for Health and Sciences, Radboud University Medical Centre, Nijmegen, The Netherlands have published the research: Lost in translation: Revisiting the use of tyrosine kinase inhibitors in colorectal cancer, in the Journal: (JOURNAL)

SUMMARY

Colorectal cancer (CRC) is the 4th most lethal cancer in the world approximately causing 900,000 deaths every year. Recent advances in treatment options including surgery, radiotherapy, chemotherapy, and targeted therapy-along with early diagnosis-have improved the overall survival (OS) rate of patients with . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.